Consensus RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq 06:00:00 11/09/26 am AEST			5-day change	1st Jan Change
74.28 ^USD	+4.81%		-0.46%	+4.11%

11/08	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT
11/08	Truist Adjusts Price Target on RadNet to $94 From $90, Maintains Buy Rating	MT

Evolution of the Average Target: RadNet, Inc.

Evolution of the Target Price: RadNet, Inc.

Changes in Analyst Recommendations: RadNet, Inc.

42c74b39ea1481ce89d169a7e3030d05.3zWOwKHbNbnJmvzc3_NiRSmL-15nCHLVjgng0f_pzks.hXL4jPeWUdei-KuejJU1d1i7ujIAZj2S2WWzjpSuuDKLR7eH4IRTir3yjw~34b7b9b8aa9b2ed0f63f0002bbd30bf3

Analysts' recommendations: RadNet, Inc.

11/08	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT
11/08	Truist Adjusts Price Target on RadNet to $94 From $90, Maintains Buy Rating	MT
02/05	B. Riley Adjusts Price Target on RadNet to $83 From $87, Maintains Buy Rating	MT
01/12	B. Riley Raises Price Target on RadNet to $87 From $71, Keeps Buy Rating	MT
13/11	Truist Raises Price Target on RadNet to $90 From $81, Keeps Buy Rating	MT
03/09/25	Truist Raises Price Target on RadNet to $81 From $74, Keeps Buy Rating	MT
12/08/25	B. Riley Adjusts Price Target on RadNet to $71 From $69, Maintains Buy Rating	MT
13/06/25	B. Riley Initiates RadNet at Buy With $69 Price Target	MT
18/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
12/04/25	Truist Securities Cuts Price Target on RadNet to $74 From $88, Keeps Buy Rating	MT
23/01/25	Truist Securities Cuts Price Target on RadNet to $88 From $94, Keeps Buy Rating	MT
29/11/24	Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating	MT
12/11/24	Top Midday Gainers	MT
04/10/24	Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating	MT
23/09/24	Truist Raises Price Target on RadNet to $80 From $70, Maintains Buy Rating	MT
07/09/24	Barclays Upgrades RadNet to Overweight From Equal Weight	MT
16/07/24	Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating	MT
12/07/24	Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating	MT
15/05/24	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
29/03/24	Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	MT
07/03/24	Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	MT
04/03/24	Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	MT
09/12/23	Truist Adjusts RadNet's Price Target to $42 From $40, Maintains Buy Rating	MT
31/08/23	Truist Securities Starts RadNet at Buy With $40 Price Target	MT
26/06/23	Raymond James Raises Price Target on RadNet to $40 From $35, Keeps Outperform Rating	MT

More recommendations

Medical & Diagnostic Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RADNET, INC.					+27.39%
	NATERA, INC.					+5.58%
	LABCORP HOLDINGS INC.					+11.24%
	SONIC HEALTHCARE LIMITED					+15.93%
	DR. LAL PATHLABS LIMITED					+1.83%
	GENEDX HOLDINGS CORP.					+7.72%
	NEOGENOMICS, INC.					+11.99%
	FLEURY S.A.					-11.9%
	GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.					+19.49%
	VIJAYA DIAGNOSTIC CENTRE LIMITED					+2.1%
	Average					+9.14%
	Weighted average by Cap.					+8.90%